Jen has volunteered her time to help educate federal legislators on Biogen’s public policy goals. She has traveled to DC several times to meet with Biogen’s Government Affairs team and members of Congress. She has a unique talent for explaining the complexities of drug pricing and value-based contracting so that members of Congress and their staff understand them.